TCR2 Therapeutics Inc
F:2K7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TCR2 Therapeutics Inc
F:2K7
|
US |
|
I
|
Intek Group SpA
F:MTJ3
|
IT |
|
A
|
AM Locales Property SOCIMI SA
MAD:YAML
|
ES |
|
Mermaid Maritime PCL
SGX:DU4
|
TH |
|
Capral Ltd
ASX:CAA
|
AU |
|
M
|
Mittel SpA
MIL:MIT
|
IT |
Dividends
Dividend Yield
TCR2 Therapeutics Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
TCR2 Therapeutics Inc
Payout Ratio
TCR2 Therapeutics Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 2K7 is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
2K7 Price
TCR2 Therapeutics Inc
| Average Annual Return | -78.5% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -96% |
| Market Capitalization | 56.6m EUR |
| Shares Outstanding | 39 261 700 |
| Percentage of Shares Shorted |
N/A
|
